Hui Xiao
Company: Eli Lilly & Co.
Job title: Advisor, Digital Health R&D
Seminars:
Workshop C: Harnessing Digital Biomarkers for Internal Decision-Making in Alzheimer’s & Parkinson’s Disease 1:30 pm
As the FDA moves towards defining digital biomarkers as digital health assessments, wearable technology becomes more refined and digital markers can provide early signs of drug efficacy. Digital biomarkers can support with earlier detection to provide more longitudinal and frequent assessment, but also support internal decision making for biopharma by better predicting drug efficacy. Look…Read more
day: Pre-Conference Workshop Day